UROGEN PHARMA LTD share price logo

UROGEN PHARMA LTD Share Price

NASDAQ: URGN

Small Cap

$18.00

-0.61

(-3.28%)

as on

UROGEN PHARMA LTD Stock Performance

as on April 8, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $17.75
    $18.58
    downward going graph

    1.39%

    Downside

    3.22%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.42
    $30.00
    downward going graph

    81.00%

    Downside

    66.67%

    Upside

    downward going graph

UROGEN PHARMA LTD share price movements today

Previous Close
$18.61
Open
$18.45
Volume
416.5K
Day's Low - High
$17.75 - $18.58
52 Week Low - High
$3.42 - $30.00

UROGEN PHARMA LTD Historical Returns

1 Month Return
-9.04 %
3 Month Return
-19.58 %
1 Year Return
+ 86.85 %
3 Year Return
+ 111.48 %
5 Year Return
-4.52 %

UROGEN PHARMA LTD Stock Fundamentals & Key Indicators

Check UROGEN PHARMA LTD market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$916.2M

EPS (TTM)

-1.1663

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-124.6M

Revenue (TTM)

109.8M

Profit Margin

-139.81%

Return On Equity TTM

-1481.26%

UROGEN PHARMA LTD vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of UROGEN PHARMA LTD with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
UROGEN PHARMA LTD image
UROGEN PHARMA LTD
BUY$916.2M-4.52%NA-139.81%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.3B134.83%136.858.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.4B104.17%28.6632.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.7BNA126.855.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.5B58.38%18.3831.41%

Stock Returns calculator for UROGEN PHARMA LTD Stock including INR - Dollar returns

The UROGEN PHARMA LTD stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

UROGEN PHARMA LTD investment value today

Current value as on today

₹1,95,718

Returns

₹95,718

(+95.72%)

Returns from UROGEN PHARMA LTD Stock

₹80,723 (+80.72%)

Dollar Impact

₹14,995 (+15%)

Analyst Recommendation on UROGEN PHARMA LTD Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for UROGEN PHARMA LTD. Average target price of $35.62

UROGEN PHARMA LTD Share Price Target

Get share price movements and forecasts by analysts on UROGEN PHARMA LTD.

What analysts predicted

49.47%UPSIDE

Target Price

$35.62

Current Price

$18

Analyzed by

11 Analysts

Target

$35.62

UROGEN PHARMA LTD target price $35.62, a slight upside of 49.47% compared to current price of $18. According to 11 analysts rating.

UROGEN PHARMA LTD Stock’s Investor Sentiment and Interest

Search interest for UROGEN PHARMA LTD Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-16% versus previous 30 day period

UROGEN PHARMA LTD Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
20
23
18
21
25
24
20
24
27
37
Gross Profit
18
21
17
19
22
22
17
20
24
34
Operating Income
-13
-14
-25
-25
-17
-27
-36
-41
-27
-19
EBITDA
-12
-7
-23
-29
-14
-26
-38
-48
-25
-22
Interest Expense
3
3
2
3
2
3
4
8
7
13
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-21
-22
-32
-33
-23
-34
-43
-48
-34
-26
Income Tax Expense
0
3
0
0
0
2
0
1
-1
0
Net Income
-21
-26
-32
-33
-23
-37
-43
-49
-33
-26
Net Profit Margin
-104.93%
-110.57%
-171.91%
-152.89%
-93.93%
-152.71%
-216.47%
-206.24%
-121.34%
-69.68%

UROGEN PHARMA LTD Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
17
8
1
0
11
48
64
82
90
109
Gross Profit
17
7
0
0
10
42
56
73
81
97
Operating Income
0
-19
-77
-109
-126
-92
-79
-65
-96
-124
EBITDA
1
-19
-76
-108
-124
-91
-76
-60
-95
-135
Interest Expense
-
-
-
0
3
17
8
14
12
33
Depreciation
-
0
0
1
2
1
1
1
1
2
Income Before Tax
-1
-19
-75
-105
-125
-109
-108
-98
-124
-153
Income Tax Expense
-
0
0
-4
3
1
1
3
2
0
Net Income
-1
-20
-75
-105
-128
-110
-109
-102
-126
-153
Net Profit Margin
-11.07%
-245.16%
-6707.18%
-584144.44%
-1088.94%
-230.67%
-170.58%
-123.61%
-140.35%
-139.81%

UROGEN PHARMA LTD Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-26
-32
-33
-23
-37
-43
-49
-33
-26
Operating Cash Flow
-13
-31
-23
-27
-13
-42
-39
-42
-38
Investing Cash Flow
-11
13
11
-106
60
-25
28
31
27
Financing Cash Flow
0
54
100
39
0
0
0
8
31
Change in Cash
-24
36
88
-94
47
-67
-11
-2
20

UROGEN PHARMA LTD Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-20
-75
-105
-128
-110
-109
-102
-126
-153
Operating Cash Flow
-9
-37
-71
-105
-84
-87
-76
-96
-162
Investing Cash Flow
-36
35
-145
93
4
1
0
-20
61
Financing Cash Flow
61
66
165
16
72
97
116
194
39
Change in Cash
15
64
-51
3
-8
10
39
77
-60

Global Institutional Holdings in UROGEN PHARMA LTD

Funds
Holdings
Rosalind Advisors, Inc.
1.17%
The Toronto-Dominion Bank
6.55%
BlackRock Inc
5.3%
Jefferies Financial Group Inc
4.52%
Soleus Capital Management, L.P.
4.72%
See all

Insights on UROGEN PHARMA LTD

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, URGN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -49.94M → -26.36M (in $), with an average increase of 38.1% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, URGN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 20.25M → 37.83M (in $), with an average increase of 18.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, URGN stock has moved down by -1.7%

About UROGEN PHARMA LTD

urogen pharma ltd. (nasdaq:urgn) is a clinical-stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology, with a focus on uro-oncology. the company has developed rtgel™, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. urogen pharma's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. urogen pharma's lead product candidates, mitogel™ (mitomycin urothelial gel) and vesigel™ (mitomycin intravesical gel), are designed to potentially remove tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial carcinoma and bladder cancer, respectively. urogen pharma is headquartered in ra’anana, israel with u.s. headquarters in new york.
OrganisationUROGEN PHARMA LTD
Headquarters400 Alexander Park Drive, Princeton, NJ, United States, 08540
IndustryHealth Technology
CEOMs. Elizabeth A. Barrett
E-voting on sharesClick here to vote

Key Management of UROGEN PHARMA LTD

Name

Title

Mr. Michael J. Louie M.D., M.P.H., M.Sc.

Chief Development Officer

Ms. Elizabeth A. Barrett

President, CEO & Director

Mr. Christopher Degnan CPA

Chief Financial Officer

Mr. Jason Drew Smith J.D.

General Counsel, Chief Compliance Officer & Corporate Secretary

Mr. Bryon Wornson

Executive Vice President of Talent, Advocacy & Communications

Dr. Mark P. Schoenberg M.D.

Chief Medical Officer

Mr. James Ottinger R.ph.

Executive Vice President of Regulatory Affairs & Quality

Mr. Vincent I. Perrone

Senior Director of Investor Relations

Dr. Marina Konorty Ph.D.

Executive Vice President of Research & Development and Technical Operations

Mr. David Lin

Chief Commercial Officer

FAQs

What is UROGEN PHARMA LTD share price today?

UROGEN PHARMA LTD share price today is $18 as on at the close of the market. UROGEN PHARMA LTD share today touched a day high of $18.58 and a low of $17.75.

What is the 52 week high and 52 week low for UROGEN PHARMA LTD share?

UROGEN PHARMA LTD share touched a 52 week high of $30 on and a 52 week low of $3.42 on . UROGEN PHARMA LTD stock price today i.e. is closed at $18,which is 40.00% down from its 52 week high and 426.32% up from its 52 week low.

What is UROGEN PHARMA LTD's market capitalisation today?

UROGEN PHARMA LTD market capitalisation is $0.00T as on .

How to invest in UROGEN PHARMA LTD Stock (URGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for UROGEN PHARMA LTD on INDmoney app. Click on Buy button. You can invest as low as $1.5 in UROGEN PHARMA LTD Shares that will get you 0.0833 shares as per UROGEN PHARMA LTD share price of $18 per share as on April 8, 2026 at 1:29 am IST.

What is the minimum amount required to buy UROGEN PHARMA LTD Stock (URGN) from India?

Indian investors can start investing in UROGEN PHARMA LTD (URGN) shares with as little as ₹93.0075 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.07 in UROGEN PHARMA LTD stock (as per the Rupee-Dollar exchange rate as on ). Based on UROGEN PHARMA LTD share’s latest price of $18 as on April 8, 2026 at 1:29 am IST, you will get 0.5556 shares of UROGEN PHARMA LTD. Learn more about fractional shares .

What are the returns that UROGEN PHARMA LTD has given to Indian investors in the last 5 years?

UROGEN PHARMA LTD stock has given -4.52% share price returns and 25.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?